ArticleMaterials (Basel, Switzerland)2025
Strategies to Enhance Yield of Wet-Synthesized Hydroxyapatite Nanocrystals and Consequences for Drug-Release Kinetics.
Article in Materials (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Efficient production of nanocrystalline hydroxyapatite with desirable properties is a key focus in research on nanomaterials based on this mineral. It has been shown that, in the widely used wet synthesis method, fundamental factors such as the choice of calcium source and the type of post-reaction suspension maturation can play a crucial role. This study examines the influence of these two factors on parameters including synthesis yield, crystal size and morphology, material crystallinity and specific surface area, variations in OH group content, and the Ca/P molar ratio. The effect of these factors on drug release from tablets containing the synthesized hydroxyapatites was also evaluated. The results clearly demonstrate that calcium acetate decreases the synthesis yield of hydroxyapatite nanocrystals, particularly under dynamic maturation conditions. Moreover, this calcium source exerts the strongest influence on the drug release profile from tablets incorporating the obtained hydroxyapatite.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.